NCT02056431View on ClinicalTrials.gov

Balancing Treatment Outcomes and Medication Burden Among Patients With Symptomatic Diabetic Peripheral Neuropathy

NACompletedINTERVENTIONAL
Enrollment

1,270

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Diabetic Peripheral Neuropathy
Interventions
BEHAVIORAL

IVR Intervention Group

Participants will receive 3 interactive voice response (IVR) calls (2nd, 4th, and 6th month post-treatment start date) to collect information on medication use, side effects, rating of side effects, and pain symptoms to be fed back to their physicians.

Trial Locations (1)

94612

Division of Research Kaiser Permanente, Oakland

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Kaiser Permanente

OTHER

NCT02056431 - Balancing Treatment Outcomes and Medication Burden Among Patients With Symptomatic Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter